| pubmed-article:8116815 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8116815 | lifeskim:mentions | umls-concept:C2825164 | lld:lifeskim |
| pubmed-article:8116815 | lifeskim:mentions | umls-concept:C0021247 | lld:lifeskim |
| pubmed-article:8116815 | lifeskim:mentions | umls-concept:C0242618 | lld:lifeskim |
| pubmed-article:8116815 | lifeskim:mentions | umls-concept:C0014508 | lld:lifeskim |
| pubmed-article:8116815 | lifeskim:mentions | umls-concept:C0206255 | lld:lifeskim |
| pubmed-article:8116815 | lifeskim:mentions | umls-concept:C0242485 | lld:lifeskim |
| pubmed-article:8116815 | lifeskim:mentions | umls-concept:C0032150 | lld:lifeskim |
| pubmed-article:8116815 | lifeskim:mentions | umls-concept:C0681916 | lld:lifeskim |
| pubmed-article:8116815 | lifeskim:mentions | umls-concept:C0750572 | lld:lifeskim |
| pubmed-article:8116815 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
| pubmed-article:8116815 | lifeskim:mentions | umls-concept:C0680844 | lld:lifeskim |
| pubmed-article:8116815 | lifeskim:mentions | umls-concept:C0021249 | lld:lifeskim |
| pubmed-article:8116815 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:8116815 | pubmed:dateCreated | 1994-3-25 | lld:pubmed |
| pubmed-article:8116815 | pubmed:abstractText | Malaria epidemiologic and entomologic studies were performed during both the high transmission and low transmission seasons to characterize the Plasmodium falciparum malaria transmission at a proposed malaria vaccine trial site in Irian Jaya, Indonesia. The study population consisted of two subsets: native Irianese men with lifelong exposure to malaria and transmigrants who arrived from a nonmalarious area 2.5 years before the start of the study. All subjects received a radical cure for malaria and were then monitored weekly by blood film. Both P. falciparum malaria attack rates and incidence densities were calculated; transmigrants had a significantly higher rate (P = 0.003) than the Irianese during the low transmission season study (20-weeks long) but not during the high transmission season study (12-weeks long). Lack of exposure-induced immunity left the transmigrants at a minimum 17-25% greater relative risk of becoming parasitemic compared with the Irianese during the low transmission season study. During the high transmission season study, 50% of the transmigrants were P. falciparum positive by week 6 and 50% of the Irianese by week 9. During the low transmission season, 50% of the transmigrants were positive by week 10 and 43% of the Irianese were positive by week 17. Entomologic studies showed that Anopheles koliensis was the predominant vector (> 98% of anopheline catch). Entomologic inoculation rates for P. falciparum were 0.018 and 0.39 infective bites/person/night for the low and high transmission seasons, respectively. New P. vivax cases represented between 16% and 42% of all initial malaria cases.(ABSTRACT TRUNCATED AT 250 WORDS) | lld:pubmed |
| pubmed-article:8116815 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8116815 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8116815 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8116815 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8116815 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8116815 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:8116815 | pubmed:issn | 0002-9637 | lld:pubmed |
| pubmed-article:8116815 | pubmed:author | pubmed-author:Purnomo | lld:pubmed |
| pubmed-article:8116815 | pubmed:author | pubmed-author:GunawanSS | lld:pubmed |
| pubmed-article:8116815 | pubmed:author | pubmed-author:JonesT RTR | lld:pubmed |
| pubmed-article:8116815 | pubmed:author | pubmed-author:HoffmanS LSL | lld:pubmed |
| pubmed-article:8116815 | pubmed:author | pubmed-author:BairdJ KJK | lld:pubmed |
| pubmed-article:8116815 | pubmed:author | pubmed-author:BangsM JMJ | lld:pubmed |
| pubmed-article:8116815 | pubmed:author | pubmed-author:BasriHH | lld:pubmed |
| pubmed-article:8116815 | pubmed:author | pubmed-author:AnnisB ABA | lld:pubmed |
| pubmed-article:8116815 | pubmed:author | pubmed-author:McElroyP DPD | lld:pubmed |
| pubmed-article:8116815 | pubmed:author | pubmed-author:HarjosuwarnoS... | lld:pubmed |
| pubmed-article:8116815 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8116815 | pubmed:volume | 50 | lld:pubmed |
| pubmed-article:8116815 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8116815 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8116815 | pubmed:pagination | 210-8 | lld:pubmed |
| pubmed-article:8116815 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8116815 | pubmed:meshHeading | pubmed-meshheading:8116815-... | lld:pubmed |
| pubmed-article:8116815 | pubmed:meshHeading | pubmed-meshheading:8116815-... | lld:pubmed |
| pubmed-article:8116815 | pubmed:meshHeading | pubmed-meshheading:8116815-... | lld:pubmed |
| pubmed-article:8116815 | pubmed:meshHeading | pubmed-meshheading:8116815-... | lld:pubmed |
| pubmed-article:8116815 | pubmed:meshHeading | pubmed-meshheading:8116815-... | lld:pubmed |
| pubmed-article:8116815 | pubmed:meshHeading | pubmed-meshheading:8116815-... | lld:pubmed |
| pubmed-article:8116815 | pubmed:meshHeading | pubmed-meshheading:8116815-... | lld:pubmed |
| pubmed-article:8116815 | pubmed:meshHeading | pubmed-meshheading:8116815-... | lld:pubmed |
| pubmed-article:8116815 | pubmed:meshHeading | pubmed-meshheading:8116815-... | lld:pubmed |
| pubmed-article:8116815 | pubmed:meshHeading | pubmed-meshheading:8116815-... | lld:pubmed |
| pubmed-article:8116815 | pubmed:meshHeading | pubmed-meshheading:8116815-... | lld:pubmed |
| pubmed-article:8116815 | pubmed:meshHeading | pubmed-meshheading:8116815-... | lld:pubmed |
| pubmed-article:8116815 | pubmed:meshHeading | pubmed-meshheading:8116815-... | lld:pubmed |
| pubmed-article:8116815 | pubmed:meshHeading | pubmed-meshheading:8116815-... | lld:pubmed |
| pubmed-article:8116815 | pubmed:meshHeading | pubmed-meshheading:8116815-... | lld:pubmed |
| pubmed-article:8116815 | pubmed:meshHeading | pubmed-meshheading:8116815-... | lld:pubmed |
| pubmed-article:8116815 | pubmed:meshHeading | pubmed-meshheading:8116815-... | lld:pubmed |
| pubmed-article:8116815 | pubmed:meshHeading | pubmed-meshheading:8116815-... | lld:pubmed |
| pubmed-article:8116815 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:8116815 | pubmed:articleTitle | Malaria vaccine study site in Irian Jaya, Indonesia: Plasmodium falciparum incidence measurements and epidemiologic considerations in sample size estimation. | lld:pubmed |
| pubmed-article:8116815 | pubmed:affiliation | Malaria Program, Naval Medical Research Institute, Bethesda, Maryland. | lld:pubmed |
| pubmed-article:8116815 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8116815 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8116815 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8116815 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8116815 | lld:pubmed |
